Research and Analysis of the Blood Screening Market: Size and Share Insights

Posted September 25, 2023 by DelvensUSA

The Blood Screening market size is projected to reach a CAGR of 8.5% from 2020 to 2028.

This Blood Screening Market report provides market segmentation in the most detailed pattern. A high-level market analysis of major segments has been performed in the report and opportunities are identified. The market report not only deals with major industrial categories but also different associated segments such as services, technologies, & applications. What is more, the Blood Screening Market research report provides market data in such a way that it also considers new product development from beginning to launch.
Blood Screening Market By Type (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Next-Generation Sequencing (NGS), Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, Hiv/Aids, Others), Application (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Market Overview
The Blood Screening market size is projected to reach a CAGR of 8.5% from 2020 to 2028.
Get a Sample Copy of the Report:

Blood screening is a procedure or a diagnostic test which is used for the pre-diagnosis of any microbiology or viral infection in the body with the help of blood testing. The 3 main blood tests are 1. Complete blood count 2. Metabolic panel and 3. lipid panel. Blood Screening takes about 5-10 minutes for the full procedure but may take longer if the vein of the person is difficult to identify.
The increased incidents of infectious diseases along with the recent surge in demand for donated blood and more people getting involved in blood donations are some of the factors that have supported long-term expansion for Blood Screenings Market.
COVID-19 had a substantial negative effect on the market, as during the prevalent lockdown conditions the need for donated blood and the blood donation facilities both had been decreased.
Regional Analysis
North America is the most rapidly growing market and offers a huge opportunity for the industry, since the prevalence of infectious diseases has surged in the region along with the increased expenditure on the health care sector.
Key Players
• F. Hoffmann-La Roche Ltd.
• Grifols
• Abbott Laboratories, Inc.
• bioMérieux
• Bio-Rad Laboratories, Inc.
To Grow Your Business Revenue, Make an Inquiry Before Buying at:

Recent Developments
• In May 2021, SARS-CoV-2 IgG was brought into the market by Beckmann Coulter
• In September 2021, Roche Diagnostics completely took over TIB Molbiol Group.
Reasons to Acquire
• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Blood Screening s Market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Table of Contents
Blood Screening s Market is segmented into Product & service, technology, end user and region.
On the basis of Product and Service
• Reagents & Kits
• NAT Reagents & Kits
• Enzymes & Polymerases
• Standards & Controls
• Probes & Primers
• Buffers, Nucleotides, and Solutions
• Labeling & Detection Reagents
• ELISA Reagents & Kits
• Immunosorbents
• Controls
• Conjugates
• Substrates
• Sample Diluents & Wash Solutions
• Other Reagents & Kits
• Instruments
• Rental Purchase
• Outright Purchase
• Software & Services
On the basis of Technology
• Nucleic Acid Test
• Transcription-mediated Amplification
• Real-time PCR
• Chemiluminescent Immunoassays
• Fluorescent Immunoassays
• Colorimetric Immunoassays
• Rapid Tests
• Western Blot Assays
• Next-generation Sequencing
On the basis of End-User
• Blood Banks
• Hospitals
On the basis of Region
• Asia Pacific
• North America
• Europe
• South America
• Middle East & Africa
Get Direct Order of this Report:

Browse Related Reports:
Periodontal Disease Treatment Market – Trends Forecast Till 2030
Next Generation Sequencing (NGS) Market – Trends Forecast Till 2030
Blood Banking Devices Market – Trends Forecast Till 2030
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports, and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on the country, regional, and global business environment. We have a database for more than 45 industries globally in more than 115+ major countries.
Delvens database assists clients by providing in-depth information on crucial business decisions. Delvens offers significant facts and figures across various industries: Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, and Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
SECTOR 90 NOIDA 201305, IN
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Delvens
Country United States
Categories Business
Last Updated September 25, 2023